Literature DB >> 11988019

Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).

Gail M Seigel1, Andrew Lotery, Ari Kummer, David J Bernard, Nicholas D E Greene, Mark Turmaine, Todd Derksen, Robert L Nussbaum, Beverly Davidson, Janet Wagner, Hannah M Mitchison.   

Abstract

Batten disease or JNCL, is the juvenile form of Neuronal Ceroid Lipofuscinosis (NCL) an autosomal recessive neurodegenerative disorder. Since retinal degeneration is an early consequence of Batten disease, we examined the eyes of Cln3 knockout mice (1-20 months of age), along with heterozygotes and appropriate controls, to determine whether or not the Cln3 defect would lead to characteristic retinal degeneration and visual loss. Accumulation of autofluorescent material and intracellular inclusions were markedly increased in Cln3 knockout retinal ganglion cells, as well as most other nuclear layers. Nerve fiber density was also significantly decreased in Cln3 knockout retinae. Apoptosis was observed in the photoreceptor layer of Cln3 knockout. However, the degree of retinal degeneration up to age 20 months was not extensive. Fundus examinations of Cln3 knockout mice showed no significant abnormalities, while electroretinograms remained robust through 11 months of age. In summary, it appears that accumulation of autofluorescent material, carbohydrate storage material, as well as apoptotic cell death are retinal manifestations of the Cln3 defect that do not appear to extinguish retinal function in this mouse model of Batten disease. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988019     DOI: 10.1006/mcne.2001.1099

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  20 in total

1.  [NCL in animal models].

Authors:  K Rüther
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

2.  Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons.

Authors:  Jill M Weimer; Andrew W Custer; Jared W Benedict; Noreen A Alexander; Evan Kingsley; Howard J Federoff; Jonathan D Cooper; David A Pearce
Journal:  Neurobiol Dis       Date:  2006-01-18       Impact factor: 5.996

3.  A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.

Authors:  Natalie A Villani; Garrett Bullock; Jennifer R Michaels; Osamu Yamato; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Gary S Johnson; Martin L Katz
Journal:  Mol Genet Metab       Date:  2019-04-17       Impact factor: 4.797

4.  CRISPR-Cas9-Mediated Correction of the 1.02 kb Common Deletion in CLN3 in Induced Pluripotent Stem Cells from Patients with Batten Disease.

Authors:  Erin R Burnight; Laura R Bohrer; Joseph C Giacalone; Darcey L Klaahsen; Heather T Daggett; Jade S East; Robert A Madumba; Kristan S Worthington; Robert F Mullins; Edwin M Stone; Budd A Tucker; Luke A Wiley
Journal:  CRISPR J       Date:  2018-02

Review 5.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 6.  Juvenile neuronal ceroid lipofuscinosis (JNCL) and the eye.

Authors:  Sara Bozorg; Denia Ramirez-Montealegre; Mina Chung; David A Pearce
Journal:  Surv Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 6.048

7.  Phenotypic characterization of a mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Martin L Katz; Gary S Johnson; Gregory E Tullis; Bo Lei
Journal:  Neurobiol Dis       Date:  2007-09-07       Impact factor: 5.996

8.  Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis.

Authors:  Jill M Weimer; Jared W Benedict; Yasser M Elshatory; Douglas W Short; Denia Ramirez-Montealegre; Deborah A Ryan; Noreen A Alexander; Howard J Federoff; Jonathan D Cooper; David A Pearce
Journal:  Brain Res       Date:  2007-05-21       Impact factor: 3.252

9.  Neurodevelopmental delay in the Cln3Deltaex7/8 mouse model for Batten disease.

Authors:  N S Osório; B Sampaio-Marques; C-H Chan; P Oliveira; D A Pearce; N Sousa; F Rodrigues
Journal:  Genes Brain Behav       Date:  2009-02-19       Impact factor: 3.449

10.  Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.

Authors:  Yu Zhong; Kabhilan Mohan; Jinpeng Liu; Ahmad Al-Attar; Penghui Lin; Robert M Flight; Qiushi Sun; Marc O Warmoes; Rahul R Deshpande; Huijuan Liu; Kyung Sik Jung; Mihail I Mitov; Nianwei Lin; D Allan Butterfield; Shuyan Lu; Jinze Liu; Hunter N B Moseley; Teresa W M Fan; Mark E Kleinman; Qing Jun Wang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-06-25       Impact factor: 6.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.